Pro-Dex: Are Stories Of Its Death Greatly Exaggerated?
5d 1m 3m 1y 5y 10y
There are 2 articles on this stock available only to PRO subscribers.
PR Newswire (Mon, 4:05PM)
PR Newswire (Feb 6, 2014)
PR Newswire (Feb 3, 2014)
PR Newswire (Dec 17, 2013)
PDEX vs. ETF Alternatives
Pro-Dex, Inc., with operations in Irvine, California and Beaverton, Oregon, designs and produces powered surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries.
Friday, Feb 712:46 PM|Friday, Feb 712:46 PM| Comment!
Tuesday, Jan 2812:45 PM|Tuesday, Jan 2812:45 PM| Comment!
Wednesday, Jan 2212:47 PM|Wednesday, Jan 2212:47 PM| 1 Comment
Wednesday, Jan 2211:47 AM
Wednesday, Jan 2211:47 AM| 2 Comments
- Pro-Dex (PDEX +16.9%) shares spike after SA Pro's Valuable Insights lays out the bull case (under embargo until 11:15am ET tomorrow) for the name, arguing in part that, "recent results understate baseline normalized earnings. On the basis of current baseline normalized earnings, shares are significantly undervalued."
Friday, Oct 42013, 12:48 PM|Friday, Oct 42013, 12:48 PM| 1 Comment
Friday, Oct 42013, 11:22 AM
Friday, Oct 42013, 11:22 AM| Comment!
- Pro-Dex (PDEX +15.5%) flies as SA Pro's Whopper Investments digs up another "net-net." The stock has struggled amid management missteps and the loss of a major customer, but activist investors have succeeded in ousting management and the board. Since these outsiders became insiders, they've been buying even more.
- The article is embargoed until tomorrow morning.
Wednesday, Sep 252013, 4:29 PM
Friday, Jan 112013, 12:45 PM
Thursday, Jan 102013, 5:50 PMSurgical tools-maker Pro-Dex (PDEX) reports a fiscal Q2 net loss of $0.11 a share, $0.02 wider than its year-ago net loss. Sales declined 25% to $3M. Shares are unchanged in after-hours trading, as the stock takes a breather following a +13.9% move during the regular session. (PR) |Thursday, Jan 102013, 5:50 PM| Comment!
Thursday, Jan 102013, 4:34 PM
Wednesday, Sep 52012, 1:41 PMPro-Dex (PDEX -4.8%) takes a hit after reporting an FQ4 loss of -$0.14 per share, versus a gain of $0.31 per share in the same year-ago period. Sales for the period decreased 46% to $3.7M. The company attributes the decrease in sales and the resulting net losses to a reduction in purchases of it's medical device products by its largest customer. |Wednesday, Sep 52012, 1:41 PM| Comment!
Thursday, Sep 152011, 1:19 PM
Wednesday, Jun 292011, 8:57 AM